Inhibikase Therapeutics (IKT) Change in Account Payables (2020 - 2026)
Inhibikase Therapeutics' Change in Account Payables was -$625,585 in Q2 2026, compared with $911,832 a year earlier.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Change in Account Payables (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Inhibikase Therapeutics' Change in Account Payables was -$1.64 million through Jun 30, 2026; for FY2025, it was $146,827, down 46.0% from FY2024.
- In earlier years, Change in Account Payables was $271,782 in FY2024, -$504,406 in FY2023, $61,395 in FY2022 and -$630,902 in FY2021.
- Quarterly Change in Account Payables has moved between -$1.98 million (Q3 2025) and $911,832 (Q2 2025) over five years.
- Per Business Quant data, IKT's Change in Account Payables in the three quarters before Q2 2026 was $429,251 (Q1 2026), $537,526 (Q4 2025) and -$1.98 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -70.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 18.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Inhibikase Therapeutics | 349.14 Mn | -236.33 Mn | - | -625,585.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -625,585.00 |
| Mar 31, 2026 | 429,251.00 |
| Dec 31, 2025 | 537,526.00 |
| Sep 30, 2025 | -1.98 Mn |
| Jun 30, 2025 | 911,832.00 |
| Mar 31, 2025 | 680,824.00 |
| Dec 31, 2024 | -1.06 Mn |
| Sep 30, 2024 | 453,434.00 |
| Jun 30, 2024 | 396,434.00 |
| Mar 31, 2024 | 479,267.00 |
| Dec 31, 2023 | -87,794.00 |
| Sep 30, 2023 | -19,585.00 |
| Jun 30, 2023 | -204,932.00 |
| Mar 31, 2023 | -192,095.00 |
| Dec 31, 2022 | 369,950.00 |
| Sep 30, 2022 | -79,221.00 |
| Jun 30, 2022 | 54,248.00 |
| Mar 31, 2022 | -283,582.00 |
| Dec 31, 2021 | 535,977.00 |
| Sep 30, 2021 | -329,174.00 |
API Access
Inhibikase Therapeutics Change in Account Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-account-payables", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();